What Elucigene Diagnostics does

Elucigene Diagnostics, operating commercially as Yourgene Health UK Ltd, is a Manchester-based molecular diagnostics company founded in 2013 that develops, manufactures, and distributes clinical assays and instrumentation for reproductive health and precision medicine. The company's core technology platform is Ranger Technology, a proprietary automated gel electrophoresis system with a patented machine vision imaging engine that powers an instrument portfolio including LightBench, LightBench Discover, LightBench Detect, NIMBUS Select, QS250, and SP150 for DNA size selection, fragment analysis up to 150 kb, and quantification.

The company sells CE-IVD and RUO diagnostic assays spanning reproductive health (IONA NIPT test for trisomy screening, Sage Prenatal Screen, Cystic Fibrosis Base, Thrombosis Risk Panel, Male Factor Infertility, Pregnancy Loss/QST*R-PL kits, Rapid Aneuploidy Analysis) and precision medicine (Elucigene DPYD and Yourgene Insight DPYD genotyping assays for chemotherapy dosing guidance). It also operates the Yourgene Genomic Services laboratory in Manchester, offering send-out NIPT sample testing (IONA Care, IONA Care+), clinical research services, and pharma services. Software and portal infrastructure (MyNIPT, Atlas Workflow Manager, IONA Analysis Software, Yourgene Flex, Sage Link) underpins workflow integration.

The business operates a B2B model with enterprise field sales targeting hospital laboratories, prenatal clinics, oncology departments, and academic research institutions, supported by regional technical service teams covering EMEA, Americas, and APAC. Revenue streams derive from diagnostic product sales (instruments and consumables with a minimum six-month shelf-life guarantee), laboratory services, and clinical research partnerships, with pricing quote-based on 30-day payment terms. The company has achieved IVDR certification for three products — DPYD genotyping (first of its kind, Nov 2023), Cystic Fibrosis Base (Oct 2024), and QST*R Base (Feb 2025) — and has expanded internationally through partnerships in Colombia (Genetix, Oct 2024) and Morocco (Laboriad, Nov 2023).

Name

Elucigene Diagnostics

Legal name

YOURGENE HEALTH UK LTD

Website

https://elucigene.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Elucigene Diagnostics (trading as Yourgene Health) is a Manchester-based molecular diagnostics company that develops Ranger Technology instruments and CE-IVD assays for NIPT, cystic fibrosis, and DPYD pharmacogenomic testing, selling to hospital labs and clinics globally via B2B field sales and laboratory services.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Molecular diagnostics
• Genetic testing assays
• Non-invasive prenatal testing
• Clinical genomics instrumentation
• Pharmacogenomic assays

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Diagnostic Products and Assays: Sale of CE-IVD and RUO diagnostic products including NIPT assays, DPYD genotyping kits, Cystic Fibrosis tests, Ranger Technology instrumentation, and consumables. Business-to-business transactions with minimum six months shelf life guarantee.
2. Laboratory Services: NIPT sample testing services through the Yourgene Genomic Services laboratory in Manchester, UK. Enables clinics to run their own NIPT service using the company's prenatal screening tests and service laboratory.
3. Research Services: Clinical research services including biomarker discovery and pharma services for pharmaceutical partnerships.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Elucigene Diagnostics, operating under the Yourgene Health brand, manufactures and distributes CE-IVD and RUO clinical diagnostic assays and Ranger® Technology instrumentation for reproductive health, precision medicine, and genomic research. The portfolio spans non-invasive prenatal testing (NIPT) workflows, DPYD genotyping kits for chemotherapy dosing guidance, cystic fibrosis and reproductive health assays, plus automated gel-electrophoresis DNA size selection instruments. The company also operates a Manchester-based genomic services laboratory offering send-out NIPT testing and clinical research services.

Product overview

Elucigene Diagnostics (operating as Yourgene Health) offers a comprehensive multi-product portfolio focused on reproductive health and precision medicine. The offering is structured as a platform-plus-modules architecture, combining Ranger® Technology as the core technology engine with specialised assays, instruments, software, and laboratory services. The Ranger® Technology platform powers the instrumentation portfolio (LightBench®, LightBench® Discover, LightBench® Detect, NIMBUS Select, Yourgene® SP150, Yourgene® QS250) for automated DNA size selection, fragment analysis, and quantification. On the assays side, the portfolio spans reproductive health (IONA® test NIPT workflows, Sage™ Prenatal Screen, Cystic Fibrosis assays, Thrombosis Risk Panel, Male Factor Infertility, Pregnancy Loss/QST*R-PL, Rapid Aneuploidy Analysis) and precision medicine (Yourgene® Insight DPYD and Elucigene® DPYD genotyping assays). Software offerings include MyNIPT portal, Atlas Workflow Manager, IONA® Analysis Software, Yourgene Flex™ Analysis Software, and Sage™ Link. Laboratory services include the NIPT Sample Service (IONA® Care, IONA® Care+), Genomic Services (extraction, microarrays, PCR, NGS), and research services (Clinical Research, Pharma Services). The product portfolio is available in both CE-IVD and RUO designations.

Differentiator

Problem solved

Functional benefit

Brands

• Elucigene: DPYD genotyping assays and precision medicine products
• Ranger Technology
• IONA
• Sage
• MagBench
• MyNIPT

Products and services

• Yourgene® Insight DPYD Assay Precision medicine assay for DPYD genotyping covering 19 variants (all AMP-recommended Tier 1 and Tier 2 plus 5 additional) to guide personalised chemotherapy dosing.
• Elucigene® DPYD DPYD genotyping assay (IVDR-certified, first product of its kind to conform with new IVDR requirements) that identifies variants affecting metabolism of certain chemotherapy drugs such as 5-fluorouracil and capecitabine.
• Cystic Fibrosis Assays Range of kits detecting CFTR gene mutations, including IVDR-certified Yourgene® Cystic Fibrosis Base and Yourgene® Cystic Fibrosis Lite, to enable appropriate treatment regimes for cystic fibrosis patients.
• IONA® Test Non-invasive prenatal screening test estimating the risk of a fetus having Trisomy 21, 18, or 13, with the ability to determine fetal sex. Uses next-generation sequencing of cell-free placental-fetal DNA from maternal blood.
• Sage™ Prenatal Screen Non-invasive prenatal screening solution estimating risk of Trisomy 21, 18, 13, Rare Autosomal Aneuploidies (RAA), Sex Chromosome Aneuploidies (SCA), and clinically relevant microdeletions.
• Yourgene Nx NIPT Workflow Complete NIPT workflow solution for screening Trisomy 21, 18, 13, Rare Autosomal Aneuploidies, Sex Chromosome Aneuploidies, and microdeletions, integrating Ranger Technology-based size selection.
• LightBench® Instrument 3-in-1 automated gel electrophoresis instrument powered by Ranger Technology offering size selection, fragment length analysis, and fluorescence-based quantification for research laboratories. Scalable with 12-sample capacity per run.
• LightBench® Discover 3-in-1 research instrument for large fragment DNA size selection, large fragment analytics, and quantification protocols up to 150 kb.
• LightBench® Detect Ranger Revolution instrument optimised for improving performance of liquid biopsy workflows and NIPT clinical applications through size selection.
• NIMBUS Select Large-scale automated electrophoresis and size selection instrument powered by Ranger Technology with 96-channel capacity, ideal for high-throughput laboratories.
• Yourgene® SP150 Automated liquid handling instrument optimised for use in Yourgene Health's clinical NIPT workflows.
• Yourgene® QS250 Instrument powered by Ranger Technology, optimised for clinical NIPT workflows; enriches fetal fraction through automated size selection of fragment lengths to reduce cost and no-call tests.
• MagBench® DNA Extraction Solution Automated DNA extraction instrument and kit designed for NIPT workflows, enabling efficient cfDNA extraction from maternal blood samples.
• Thrombosis Risk Panel Detects the four most relevant genetic mutations implicated with an increased risk of developing venous thromboembolism, enabling treatment to be offered.
• Male Factor Infertility Assay Uses QF-PCR technology and genetic analysers to detect Y-chromosome microdeletions and sex chromosome aneuploidies enabling more effective clinical management of patients.
• Pregnancy Loss / QST*R-PL Kit Kit for routine in vitro quantitative diagnosis of the six most common autosomal trisomies associated with pregnancy loss.
• Rapid Aneuploidy Analysis Rapid aneuploidy testing for prenatal and reproductive health applications, IVDR-certified.
• Yourgene® QST*R Base IVDR-accredited assay for reproductive health genetic testing.
• NIPT Sample Service (IONA® Care / IONA® Care+) Send-out NIPT testing service enabling clinics to run their own NIPT service for pregnant women, with processing at the genomic services laboratory in Manchester, UK. Includes IONA Care (standard menu) and IONA Care+ (comprehensive menu with microdeletions).
• Clinical Research and Pharma Services Biomarker discovery and pharmaceutical research services offered by Yourgene Genomic Services to support clinical research and pharma partnerships.

Quantifiable outcome

• Size selection enhances ctDNA detection signal by average AUC ratio of 1.99 in cancer patients vs 1.04 in healthy patients
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered regional, core and notable.

• Genetix (Colombia)regionalChannel Partner/ Reseller/ Distributor · 2 October 2024Launch of first local Non-invasive Prenatal Testing service in Colombia through Genetix partnership.
• PacBiocoreTechnology or Integration · 17 November 2023PacBio Compatible Partner status, enabling PacBio customers to optimize size selection for long-read sequencing libraries using Ranger Technology instruments.
• Laboriad (Morocco)regionalChannel Partner/ Reseller/ Distributor · 9 November 2023Launch of Non-invasive Prenatal Testing in Morocco through Laboriad partnership.
• Hamilton RoboticscoreStrategic or Co-development PartnerPartnership for NIMBUS Select - a fully automated gel size selection platform combining Ranger Technology with Hamilton Robotics automation for high-throughput laboratories with 96-channel capacity.
• LabcorpcoreStrategic or Co-development PartnerCollaboration on liquid biopsy research demonstrating how automated size selection using Ranger Technology enhances ctDNA detection signal in cancer patients. Joint webinar and instrument evaluation study.
• LifeStrands GenomicsnotableStrategic or Co-development PartnerPilot project collaboration for Yourgene Microdeletions Plugin Accelerator, representing a new partnership-based approach to NIPT testing solutions delivery.
• ThermoFisher (Affymetrix)notableTechnology or IntegrationAffymetrix Axiom and GeneChip arrays offered through Yourgene Genomic Services for genome-wide disease association studies and targeted genotyping.
• IlluminacoreTechnology or IntegrationNGS services using Illumina sequencing platforms for detecting SNVs, insertions, deletions, copy number changes, and structural variations.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Natera: Natera is a leading molecular diagnostics company offering NIPT (Panorama), reproductive health, and oncology testing. It directly competes with Yourgene/Elucigene in NIPT workflows and reproductive health genetic testing, serving overlapping clinical laboratory customers globally.
• Myriad Genetics: Myriad Genetics provides genetic and pharmacogenomic testing across reproductive health (Foresight carrier screening), oncology, and mental health. It is comparable to Yourgene/Elucigene in the reproductive health IVD and pharmacogenomics (DPYD-adjacent) categories.
• Centogene: Centogene offers rare disease diagnostics, reproductive health testing, and NIPT services from clinical laboratories in Europe. It directly overlaps with Yourgene's NIPT sample service and cystic fibrosis / reproductive health assay portfolio.
• Sonic Healthcare: Sonic Healthcare is a global clinical laboratory operator with significant genetic and molecular diagnostics capabilities. It is comparable to Yourgene Genomic Services as a competing provider of send-out NIPT and genetic testing services to clinics.
• NeoGenomics: NeoGenomics operates clinical laboratories providing oncology-focused molecular and genetic testing services. It overlaps with Yourgene Genomic Services in molecular diagnostics and with Yourgene's DPYD assay in the precision-medicine / oncology testing segment.

Broad incumbents

• Roche Diagnostics: Roche Diagnostics is a global IVD leader with extensive NIPT (Harmony) and reproductive health offerings. It competes with Yourgene/Elucigene across IVD products and laboratory services but at much greater scale and with broader portfolio.
• Illumina: Illumina is the dominant NGS platform provider and offers its own NIPT and genetic testing workflows. It is comparable both as a sequencing platform that Yourgene depends on and as a broader competitor in the genetic testing / NIPT space.
• PerkinElmer: PerkinElmer offers reproductive health, NIPT, and genomics laboratory services, plus instrumentation. It is comparable to Yourgene/Elucigene across NIPT products, lab services, and DNA-analysis instrumentation, though at substantially larger scale.
• Thermo Fisher Scientific: Thermo Fisher provides Affymetrix microarrays and broad genetic-analysis instrumentation, with which Yourgene integrates through its microarray services offering. It is a broad incumbent in life-science tools and genetic testing infrastructure.
• QIAGEN: QIAGEN is a leading provider of molecular diagnostics and sample-preparation technologies. It is comparable to Yourgene/Elucigene in molecular diagnostics, IVD assays, and laboratory workflow technologies, though operating at much greater scale and breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Elucigene
• Facebookfacebook.com/723613471003708

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elucigene Diagnostics